The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model.

[1]  G. Barrera.  Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy , 2012, ISRN oncology.

[2]  Brendon M. Baker,et al.  Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.

[3]  N. Fineberg,et al.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. , 2011, Free radical biology & medicine.

[4]  W. Atkins,et al.  Interactions of glutathione transferases with 4-hydroxynonenal , 2011, Drug metabolism reviews.

[5]  P. Sylvester,et al.  Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. , 2011, Methods in molecular biology.

[6]  B. Youan,et al.  Engineering nanomedicines for improved melanoma therapy: progress and promises. , 2010, Nanomedicine.

[7]  R. N. Saha,et al.  Nanoparticulate drug delivery systems for cancer chemotherapy , 2010, Molecular membrane biology.

[8]  E. Menegatti,et al.  4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity. , 2010, The Journal of nutritional biochemistry.

[9]  Peter X Ma,et al.  Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications. , 2010, Nano today.

[10]  C. Toaldo,et al.  The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer , 2010, Cancers.

[11]  P. Ferranti,et al.  Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity. , 2009, The Biochemical journal.

[12]  R. Cavalli,et al.  Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[14]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[15]  V. Vasiliou,et al.  4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells. , 2009, Biochemical and biophysical research communications.

[16]  M. Ferracin,et al.  MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. , 2009, Free radical biology & medicine.

[17]  Y. Awasthi,et al.  Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. , 2008, Free radical biology & medicine.

[18]  G. Poli,et al.  4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest , 2008, Medicinal research reviews.

[19]  Monica L Guzman,et al.  Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. , 2008, Blood.

[20]  R. Cavalli,et al.  Poly(4‐acryloylmorpholine) oligomers carrying a β‐cyclodextrin residue at one terminus , 2008 .

[21]  M. Dianzani,et al.  Lipid peroxidation: control of cell proliferation, cell differentiation and cell death. , 2008, Molecular aspects of medicine.

[22]  N. Žarković,et al.  Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells , 2007, Redox report : communications in free radical research.

[23]  H. Basaga,et al.  Apoptosis signalling by 4-hydroxynonenal: a role for JNK–c-Jun/AP-1 pathway , 2007, Redox report : communications in free radical research.

[24]  Wen-Sheng Wu.  The signaling mechanism of ROS in tumor progression , 2007, Cancer and Metastasis Reviews.

[25]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[26]  Federica Briatore,et al.  4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. , 2006, Free radical biology & medicine.

[27]  Federica Briatore,et al.  4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. , 2005, Free radical biology & medicine.

[28]  K. Conklin.  Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness , 2004, Integrative cancer therapies.

[29]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[30]  T. Grune,et al.  Intracellular metabolism of 4-hydroxynonenal. , 2003, Molecular aspects of medicine.

[31]  K. Uchida,et al.  4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. , 2003, Progress in lipid research.

[32]  M. Dianzani,et al.  4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells. , 2002, Biochemical and biophysical research communications.

[33]  N. Žarković,et al.  Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes. , 2002, Anticancer research.

[34]  S. Brüsselbach,et al.  Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal. , 1999, Free radical biology & medicine.

[35]  V. Fazio,et al.  4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. , 1996, Biochemical and biophysical research communications.

[36]  D. V. Vander Jagt,et al.  Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. , 1995, Biochimica et biophysica acta.

[37]  J. German,et al.  Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. , 1995, Chemical research in toxicology.

[38]  N. Žarković,et al.  Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal. , 1995, Cancer biotherapy.

[39]  D. Petersen,et al.  The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. , 1995, Archives of biochemistry and biophysics.

[40]  V. Fazio,et al.  Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. , 1994, Biochemical and biophysical research communications.

[41]  E. Stadtman,et al.  Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  V. Fazio,et al.  Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation. , 1991, Experimental cell research.

[43]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[44]  S. Collins,et al.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.